Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Harvey

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Lancet (London, England)|December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Nature Genetics|January 12, 2010
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci, John D Reveille, Anne-Marie Sims, et al.
Health Technology Assessment (Winchester, England)|November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
The Lancet. Infectious Diseases|October 7, 2022
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trialMartin J Llewelyn, Eric P Budgell, Magda Laskawiec-Szkonter, et al.
Nature Genetics|July 12, 2011
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibilityDavid M Evans, Chris C A Spencer, Jennifer J Pointon, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Lancet (London, England)|December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Nature Genetics|January 12, 2010
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci, John D Reveille, Anne-Marie Sims, et al.
Health Technology Assessment (Winchester, England)|November 2, 2018
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
The Lancet. Infectious Diseases|October 7, 2022
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trialMartin J Llewelyn, Eric P Budgell, Magda Laskawiec-Szkonter, et al.
Nature Genetics|July 12, 2011
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibilityDavid M Evans, Chris C A Spencer, Jennifer J Pointon, et al.
Pageof 9